Diagnosis and management of chronic and refractory immune cytopenias in children, adolescents, and young adults
- PMID: 29856527
- DOI: 10.1002/pbc.27260
Diagnosis and management of chronic and refractory immune cytopenias in children, adolescents, and young adults
Erratum in
-
Erratum to correct "Diagnosis and management of chronic and refractory immune cytopenias in children, adolescents, and young adults".Pediatr Blood Cancer. 2019 Apr;66(4):e27581. doi: 10.1002/pbc.27581. Epub 2018 Dec 28. Pediatr Blood Cancer. 2019. PMID: 30793509 No abstract available.
Abstract
Children, adolescents, and young adults with chronic refractory autoimmune cytopenias represent a rare but challenging group of patients, who are managed frequently by pediatric hematologists. Novel diagnostic tests and genomic discoveries are refining historical diagnoses of Evans syndrome and common variable immunodeficiency, while also elucidating the cellular and molecular basis for these disorders. Genetic characterization of chronic and refractory autoimmune cytopenias has led to targeted therapies with improved clinical outcomes and fewer off-target toxicities. In this review, we focus on the appropriate diagnostic workup, expanded genetic testing, and novel treatment opportunities that are available for these challenging patients.
Keywords: AIHA; CVID; Evans syndrome; ITP; alps; cytopenia; immunohematology.
© 2018 Wiley Periodicals, Inc.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
